POST-ESSENTIAL THROMBOCYTHEMIA MYELOFIBROSIS (POST-ET MF)

Clinical trials for POST-ESSENTIAL THROMBOCYTHEMIA MYELOFIBROSIS (POST-ET MF) explained in plain language.

Never miss a new study

Get alerted when new POST-ESSENTIAL THROMBOCYTHEMIA MYELOFIBROSIS (POST-ET MF) trials appear

Sign up with your email to follow new studies for POST-ESSENTIAL THROMBOCYTHEMIA MYELOFIBROSIS (POST-ET MF), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1 Not yet recruiting 1

Massive 5,000-Person study launches to map the journey of rare blood cancers

Knowledge-focused Recruiting now

This is a long-term observational study designed to better understand a group of rare, chronic blood cancers called myeloproliferative neoplasms (MPNs). It will follow 5,000 adults in the U.S. for 5-10 years, collecting health records and patient surveys to track symptoms, treatm…

Matched conditions: POST-ESSENTIAL THROMBOCYTHEMIA MYELOFIBROSIS (POST-ET MF)

Sponsor: MPN Research Foundation • Aim: Knowledge-focused

Last updated Apr 02, 2026 14:56 UTC

POST-ESSENTIAL THROMBOCYTHEMIA MYELOFIBROSIS (POST-ET MF)

Get alerted when new POST-ESSENTIAL THROMBOCYTHEMIA MYELOFIBROSIS (POST-ET MF) trials appear

Massive 5,000-Person study launches to map the journey of rare blood cancers